Replies to post #23491 on FDA Plays

[StimulatedCell]

GALE--As a long-suffering DNDN shareholder, I am a firm believer in immunotherapy going forward in the fight against cancer.

GALE sounds very interesting and potential market is large.

Anyone else looking to invest here for long haul through phase III studies?